23.10.2015
- Hedge fund manager and activist shareholder Bill Ackman has bought 2 million new shares in Valeant at an estimated total cost of $230 million. The buy is said to have increased his...
14.07.2015
- Private equity investor Platform Specialty Products has offered around $2.3 billion, including debt, for all shares of UK-based Alent, a manufacturer of electronic chemicals...
24.04.2015
- US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...
19.02.2015
- Three months after acquiring US Botox producer Allergan for $66 billion, Ireland-based drugmaker Actavis has announced it will adopt Allergan as the name of the merged corporate...
04.11.2014
- Botox maker Allergan, which is fighting a hostile takeover bid by Valeant Pharmaceutical, is said to have been approached about a potential transaction by another party. The news...
17.09.2014
- US drugmaker Allergan, which makes the Botox anti-wrinkle treatment, said it has reached agreement with suitors Pershing Square Capital Management and Canada's Valeant...
27.08.2014
- Led by the company's largest shareholder, Bill Ackman, investors owning 31% of Botox manufacturer Allergan have called for a special shareholder meeting. Ackman's investment...
26.01.2013
- What a difference a year makes for Procter & Gamble and CEO Bob McDonald. Last February, he unveiled a $10 billion restructuring including thousands of job cuts after the world's...
